Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • The Health Equity podcast
    • Access insights
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Date

13 July 2020

Jayasree K. Iyer on CNBC Africa: How is COVID-19 impacting progress on HIV, malaria, and TB?

In this 25-minute interview for CNBC Africa, Jayasree K. Iyer discusses the impact of COVID-19 on progress made against HIV, malaria, and TB in Africa. 

Jayasree K. Iyer joins CNBC Africa’s Kenneth Igbomor to explore how best to address Africa’s disease burden in the midst of the global COVID-19 crisis, which has exposed gaps in the healthcare systems around the world. 

After decades of progress made toward HIV, malaria and tuberculosis, Jayasree K. Iyer explains how children are again at heightened risk from these diseases due to disruptions caused by the novel coronavirus:

“Resources are being redirected toward COVID-19 that should be there for HIV, TB and malaria. In Nigeria, with the third-largest HIV epidemic, 35,000 extra HIV-related deaths are expected due to COVID-19." 

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved